BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aeolus Pharmaceuticals Inc. 

23811 Inverness Place

Laguna Niguel  California  92677  U.S.A.
Phone: 949-481-9825 Fax: 949-481-9829


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Aeolus Pharmaceuticals Inc. (AOLS.OB) Files Investigational New Drug Application With U.S FDA To Enable Initiation Of Human Safety Studies For The Development Of AEOL 10150 As A Medical Countermeasure Against Lung Damage From Radiation Exposure 8/20/2014 11:20:07 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Third Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 8/18/2014 9:38:16 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Additional Data Demonstrating Efficacy Of AEOL 10150 As A Medical Countermeasure Against Exposure To Nerve Agents, Sulfur Mustard Gas And Nitrogen Mustard Gas 7/1/2014 9:14:17 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Publication Of Data Demonstrating Efficacy Of AEOL 10150 In Animal CEES Model Of Mustard Gas Skin Exposure 6/18/2014 11:26:48 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) To Present At LD Micro Invitational Conference 6/3/2014 9:07:48 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Second Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 5/16/2014 9:55:38 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces First Quarter Fiscal Year 2014 Financial Results 2/17/2014 10:36:39 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Process Improvements And Positive 18 Month Stability Results For AEOL 10150 In New Formulation 2/13/2014 9:57:28 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Publication Of Data Demonstrating Efficacy Of AEOL 10150 In Animal Model Of Lung Radiation Exposure; Models Developed For Pivotal Efficacy Studies 2/11/2014 9:21:20 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Receives Orphan Drug Designation For AEOL 10150 From U.S. FDA 1/23/2014 10:16:25 AM
12345678910...